Stryker Corporation

NYSE (USD): Stryker Corporation (SYK)

Last Price

325.43

Today's Change

-2.02 (0.61%)

Day's Change

324.68 - 330.38

Trading Volume

1,665,640

Overview

Market Cap

123 Billion

Shares Outstanding

380 Million

Avg Volume

1,259,669

Avg Price (50 Days)

349.46

Avg Price (200 Days)

304.15

PE Ratio

39.35

EPS

8.27

Earnings Announcement

30-Apr-2024

Previous Close

327.45

Open

330.38

Day's Range

324.71 - 330.38

Year Range

249.98 - 361.41

Trading Volume

1,822,659

Price Change Highlight

1 Day Change

-0.62%

5 Day Change

-5.89%

1 Month Change

-7.94%

3 Month Change

3.29%

6 Month Change

22.48%

Ytd Change

9.86%

1 Year Change

7.21%

3 Year Change

23.32%

5 Year Change

78.65%

10 Year Change

309.45%

Max Change

390408.19%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment